Kathryn E. Hudson, MD, discusses the utility of liquid biopsy in lung cancer.
Kathryn E. Hudson, MD
Advertisement
Articles by Kathryn E. Hudson, MD
Kathryn E. Hudson, MD, discusses the rise of liquid biopsies as a tool for molecular testing in lung cancer.
Kathryn E. Hudson, MD, discusses performing repeat biopsies on patients with relapsed/refractory non–small cell lung cancer.
Kathryn E. Hudson, MD, discusses the utility of liquid biopsies in metastatic lung cancer.
Advertisement
Latest Updated Articles
Dr. Hudson on the Utility of Liquid Biopsy in Metastatic Lung CancerPublished: December 5th 2019 | Updated:
Dr. Hudson on Repeat Molecular Testing in Relapsed/Refractory NSCLCPublished: January 18th 2020 | Updated:
Dr. Hudson on the Rise of Liquid Biopsies in Lung CancerPublished: January 30th 2020 | Updated:
Dr. Hudson on the Utility of Liquid Biopsy in Lung CancerPublished: April 16th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts NDA for Zanzalintinib Plus Atezolizumab in Pretreated mCRC
2
Hematology Experts Preview Key Abstracts to Watch at the 2026 Transplantation & Cellular Therapy Meetings
3
Retrospective, Real-World Analysis Shows Improved OS With Apalutamide Over Darolutamide in mCSPC
4
Latest ACS Cancer Statistics Report Outlines Notable Gains, Remaining Gaps Across Tumor Types
5